MDK6620

For research use only. Not for therapeutic Use.

  • CAT Number: I031750
  • CAS Number: 304456-62-0
  • Molecular Formula: C12H9BrN2OS
  • Molecular Weight: 309.18
  • Purity: 98%
Inquiry Now

MDK6620(Cat No.:I031750), also referred to as BTYNB IMP1 Inhibitor is a compound that acts as an inhibitor of the oncofetal mRNA-binding protein IMP1. It displays an inhibitory effect on the binding of IMP1 to c-Myc mRNA, with an IC50 value of 5 μM. By targeting IMP1, MDK6620 potentially disrupts the interaction between IMP1 and c-Myc mRNA, which may have implications in cancer-related processes. Further research is necessary to explore the therapeutic potential of MDK6620 in cancer treatment and its impact on IMP1-mediated functions.


Catalog Number I031750
CAS Number 304456-62-0
Synonyms

BTYNB IMP1 Inhibitor; MDK6620; MDK-6620; MDK 6620.

Molecular Formula C12H9BrN2OS
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage 4°C, protect from light
IUPAC Name 2-[[(5-bromo-2-thienyl)methylene]amino]-benzamide
InChI InChI=1S/C12H9BrN2OS/c13-11-6-5-8(17-11)7-15-10-4-2-1-3-9(10)12(14)16/h1-7H,(H2,14,16)/b15-7+
InChIKey OZEADOPONHLEDS-VIZOYTHASA-N
SMILES O=C(N)C1=CC=CC=C1/N=C/C2=CC=C(Br)S2
Reference

1. L. Mahapatra, N. Andruska, C. Mao, et al. A novel IMP1 inhibitor, BTYNB, targets c-Myc and inhibits melanoma and ovarian cancer cell proliferation. Transl. Oncol. 10(5), 818-827 (2017).

Request a Quote